Close Menu

NEW YORK (GenomeWeb) — Cancer Genetics reported after the close of the market Monday a 26 percent drop in its third quarter revenues due to declines across its biopharma, clinical, and discovery services units.

For the three-month period ended Sept. 30, Rutherford, New Jersey-based CGI posted revenues of $5.9 million versus $8.0 million in the same period a year before.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.